Retrospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Jan 14, 2015; 21(2): 584-592
Published online Jan 14, 2015. doi: 10.3748/wjg.v21.i2.584
Figure 2
Figure 2 Cumulative posttransplant survival and hepatitis B virus recurrence rates for each group. A: Cumulative posttransplant survival; B: Cumulative posttransplant hepatitis B virus (HBV) recurrence. HBIG: Hepatitis B immunoglobulin; LAM: Lamivudine; ETV: Entecavir; ADV: Adefovir dipivoxil.